Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Cullinan Therapeutics, Inc. (CGEM) had Weighted-Average Shares Outstanding (Diluted) of 59.02M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-70.06M |
|
-- |
|
-- |
|
$75.80M |
|
$-75.80M |
|
$5.74M |
|
$-70.06M |
|
$-70.06M |
|
$-70.06M |
|
$-70.06M |
|
$-70.06M |
|
$-70.06M |
|
$-75.80M |
|
$-75.72M |
|
59.02M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
59.02M |
$-1.07 |
|
$-1.07 |
|
| Balance Sheet Financials | |
$275.91M |
|
$0.57M |
|
$244.42M |
|
$520.33M |
|
$28.06M |
|
-- |
|
$0.12M |
|
$28.18M |
|
$492.15M |
|
$492.15M |
|
$492.15M |
|
59.07M |
|
| Cash Flow Statement Financials | |
$-100.76M |
|
$90.21M |
|
$0.37M |
|
$83.00M |
|
$72.82M |
|
$-10.19M |
|
$19.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-100.76M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.23% |
|
-14.23% |
|
-13.46% |
|
-14.23% |
|
$8.33 |
|
$-1.71 |
|
$-1.71 |
|